A new compound has been found to target mitochondrial damage in models of Parkinson's disease, potentially leading to a treatment for the condition. The compound may also have benefits beyond Parkinson's, including reducing life-threatening lung injury. The discovery is being explored for its therapeutic potential, with some reports suggesting it could enter clinical trials.